Texas federal judge Matthew Kacsmaryk, who recently ruled to suspend the Food and Drug Administration’s (FDA) approval of the abortion drug mifepristone, failed to disclose two interviews he did prior to his confirmation in which he spread dangerous lies about LGBTQ people, despite requirements for federal judicial nominees to do so. Twice in 2014, Donald Trump-nominated Kacsmaryk appeared on a…
BROADCASTING FOR INDEPENDENCE
